Novel inhalable gene therapy trialed for people with cystic fibrosis

by

An inhalable medicine with the potential to improve lung disease in people with cystic fibrosis, irrespective of their mutation type, is being tested in human trials in the UK and Europe.

Leave A Comment

Your email address will not be published. Required fields are marked *